NEWBURY PARK, Calif. & RALEIGH, N.C.–(BUSINESS WIRE)–Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full.
Practices using Phreesia and Compulink will now be able to automate time-consuming processes like managing vision and medical eligibility & benefits (E&B) verification, collecting payments, and capturing demographic, clinical and financial data, and consents—all of which will be completed digitally by patients and saved directly in Compulink.
“Compulink is committed to giving practices more options to enhance their intake experience, and we’re excited to offer them this integration with Phreesia,” said Link Wilson, CEO and Product Architect. “The features available through Phreesia’s integration will help our practices maximize their profitability and efficiency alongside Advantage SMART Practice®.”
With Phreesia, Compulink customers can:
“For more than 17 years, Phreesia has been focused on improving the patient experience and giving our clients a top-ranked patient intake solution,” said Phreesia CEO Chaim Indig. “With 100 million patient visits enabled by our platform in a year, we’re excited to bring our scale and expertise to this partnership with Compulink, which we believe will drive significant value for practices.”
About Compulink Healthcare Solutions
A leader in specialty specific EHR and Practice Management for 37 years, our all-in-one solution enables today’s private practice to deliver personalized patient care more efficiently for better outcomes and financial performance. With more smart features to automate patient flow and speed documentation, Compulink offers the industry’s only specialty specific EHR solution that adapts to your workflow.
About Phreesia
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.
Phreesia Forward-Looking Statements
This press release includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These statements include, but are not limited to, statements regarding plans, objectives, intentions and expectations regarding future performance, including statements regarding the expected results and benefits of Phreesia’s partnership with Compulink. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although Phreesia’s management believes that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in, or implied by, forward-looking statements and are subject to a variety of risks and uncertainties, many of which are difficult to predict and are generally beyond the control of Phreesia. These risks and uncertainties include, but are not limited to, risks associated with: the possibility that the integration may be more difficult, time-consuming or costly than expected or that the intended benefits of Phreesia’s partnership with Compulink will not be realized when expected or at all; changes in laws and regulations applicable to Phreesia’s business model; changes in market conditions and receptivity to Phreesia’s products and services; Phreesia’s ability to effectively manage its growth and meet its growth objectives; Phreesia’s ability to maintain the security and availability of its platform; Phreesia’s ability to make accurate predictions about its industry; the impact of the COVID-19 pandemic on Phreesia’s business and economic conditions; and Phreesia’s ability to attract, retain and cross-sell to healthcare services clients. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Phreesia’s filings with the Securities and Exchange Commission (“SEC”), including Phreesia’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022, as updated by Phreesia’s subsequently filed Quarterly Reports on Form 10-Q, and other SEC filings. The forward-looking statements in this press release speak only as of the date on which the statements are made. Phreesia undertakes no obligation to update, and expressly disclaims the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
Contacts
Media:
Compulink:
Trevor Wilson
press@compulinkadvantage.com
Phreesia:
Annie Harris
aharris@phreesia.com
929-526-2611
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…